The Latin America, Middle East and Africa Joint Pain Injections Market should witness market growth of 10.6% CAGR during the forecast period (2022-2028).
The orthopedic physician may offer several types of joint paininjections based on theunique treatment plan. Injections epidurals are used to treat spinal discomfort as well as pain in the legs or arms caused by an irritated spinal nerve. Epidural injections, like corticosteroid injections, combine an anesthetic with a corticosteroid. Injecting corticosteroids into the epidural area immediately outside of the spinal cord distinguishes an epidural from a conventional corticosteroid injection.
Sacroiliac injections are comparable to facial joint injections, except that they are administered into the sacroiliac joint, which joins the sacral area of the spine to the pelvis. These injections are intended to treat pain in the sacroiliac joint andlower back buttock, and leg pain. Typically, only one side of the body is affected by discomfort.
The UAE healthcare industry has grown to accommodate both the country's expanding population and its aspiration to establish itself as a major regional center for medical tourism. Healthcare is a key area for the UAE government, according to Vision 2040, and the nation will continue to be a desirable place for the establishment of a regional distribution center for healthcare services.
The World Bank 2012 report estimates that 4.7% of the 336 million people living in the Middle East and Northern Africa (MENA) are over the age of 65. An enormous healthcare burden results from this aging population. This intensifies the local problem of joint discomfort. All of these factors suggest that the joint pain injections market in the area will expand significantly.
The Brazil market dominated the LAMEA Joint Pain Injections Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $186.3 Million by 2028. The Argentina market is showcasing a CAGR of 11.2% during (2022-2028). Additionally, The UAE market would register a CAGR of 10.3% during (2022-2028).
Based on Injection Type, the market is segmented into Interleukin Inhibitors, Hyaluronic Acid Injections, and Others. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Others. Based on Joint Type Channel, the market is segmented into Knee & Ankle, Shoulder & Elbow, Hip Joint, Facet Joints of the Spine, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bioventus Inc., Pacira BioSciences, Inc., AbbVie, Inc., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc., Anika Therapeutics, Inc., Zimmer Biomet Holdings, Inc., Eli Lilly And Company, Ferring Holdings SA, and Sanofi S.A.
The orthopedic physician may offer several types of joint paininjections based on theunique treatment plan. Injections epidurals are used to treat spinal discomfort as well as pain in the legs or arms caused by an irritated spinal nerve. Epidural injections, like corticosteroid injections, combine an anesthetic with a corticosteroid. Injecting corticosteroids into the epidural area immediately outside of the spinal cord distinguishes an epidural from a conventional corticosteroid injection.
Sacroiliac injections are comparable to facial joint injections, except that they are administered into the sacroiliac joint, which joins the sacral area of the spine to the pelvis. These injections are intended to treat pain in the sacroiliac joint andlower back buttock, and leg pain. Typically, only one side of the body is affected by discomfort.
The UAE healthcare industry has grown to accommodate both the country's expanding population and its aspiration to establish itself as a major regional center for medical tourism. Healthcare is a key area for the UAE government, according to Vision 2040, and the nation will continue to be a desirable place for the establishment of a regional distribution center for healthcare services.
The World Bank 2012 report estimates that 4.7% of the 336 million people living in the Middle East and Northern Africa (MENA) are over the age of 65. An enormous healthcare burden results from this aging population. This intensifies the local problem of joint discomfort. All of these factors suggest that the joint pain injections market in the area will expand significantly.
The Brazil market dominated the LAMEA Joint Pain Injections Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $186.3 Million by 2028. The Argentina market is showcasing a CAGR of 11.2% during (2022-2028). Additionally, The UAE market would register a CAGR of 10.3% during (2022-2028).
Based on Injection Type, the market is segmented into Interleukin Inhibitors, Hyaluronic Acid Injections, and Others. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Others. Based on Joint Type Channel, the market is segmented into Knee & Ankle, Shoulder & Elbow, Hip Joint, Facet Joints of the Spine, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bioventus Inc., Pacira BioSciences, Inc., AbbVie, Inc., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc., Anika Therapeutics, Inc., Zimmer Biomet Holdings, Inc., Eli Lilly And Company, Ferring Holdings SA, and Sanofi S.A.
Scope of the Study
By Injection Type
- Interleukin Inhibitors
- Hyaluronic Acid Injections
- Others
By Distribution Channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Others
By Joint Type
- Knee & Ankle
- Shoulder & Elbow
- Hip Joint
- Facet Joints of the Spine
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Bioventus Inc.
- Pacira BioSciences, Inc.
- AbbVie, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Pfizer, Inc.
- Anika Therapeutics, Inc.
- Zimmer Biomet Holdings, Inc.
- Eli Lilly And Company
- Ferring Holdings SA
- Sanofi S.A.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Joint Pain Injections Market, by Injection Type
1.4.2 LAMEA Joint Pain Injections Market, by Distribution Channel
1.4.3 LAMEA Joint Pain Injections Market, by Joint Type
1.4.4 LAMEA Joint Pain Injections Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Joint Pain Injections Market by Injection Type
3.1 LAMEA Interleukin Inhibitors Market by Country
3.2 LAMEA Hyaluronic Acid Injections Market by Country
3.3 LAMEA Others Market by Country
Chapter 4. LAMEA Joint Pain Injections Market by Distribution Channel
4.1 LAMEA Drug Stores & Retail Pharmacies Market by Country
4.2 LAMEA Hospital Pharmacies Market by Country
4.3 LAMEA Others Market by Country
Chapter 5. LAMEA Joi nt Pain Injections Market by Joint Type
5.1 LAMEA Knee & Ankle Market by Country
5.2 LAMEA Shoulder & Elbow Market by Country
5.3 LAMEA Hip Joint Market by Country
5.4 LAMEA Facet Joints of the Spine Market by Country
5.5 LAMEA Others Market by Country
Chapter 6. LAMEA Joint Pain Injections Market by Country
6.1 Brazil Joint Pain Injections Market
6.1.1 Brazil Joint Pain Injections Market by Injection Type
6.1.2 Brazil Joint Pain Injections Market by Distribution Channel
6.1.3 Brazil Joint Pain Injections Market by Joint Type
6.2 Argentina Joint Pain Injections Market
6.2.1 Argentina Joint Pain Injections Market by Injection Type
6.2.2 Argentina Joint Pain Injections Market by Distribution Channel
6.2.3 Argentina Joint Pain Injections Market by Joint Type
6.3 UAE Joint Pain Injections Market
6.3.1 UAE Joint Pain Injections Market by Injection Type
6.3.2 UAE Joint Pain Injections Market by Distribution Channel
6.3.3 UAE Joint Pain Injections Market by Joint Type
6.4 Saudi Arabia Joint Pain Injections Market
6.4.1 Saudi Arabia Joint Pain Injections Market by Injection Type
6.4.2 Saudi Arabia Joint Pain Injections Market by Distribution Channel
6.4.3 Saudi Arabia Joint Pain Injections Market by Joint Type
6.5 South Africa Joint Pain Injections Market
6.5.1 South Africa Joint Pain Injections Market by Injection Type
6.5.2 South Africa Joint Pain Injections Market by Distribution Channel
6.5.3 South Africa Joint Pain Injections Market by Joint Type
6.6 Nigeria Joint Pain Injections Market
6.6.1 Nigeria Joint Pain Injections Market by Injection Type
6.6.2 Nigeria Joint Pain Injections Market by Distribution Channel
6.6.3 Nigeria Joint Pain Injections Market by Joint Type
6.7 Rest of LAMEA Joint Pain Injections Market
6.7.1 Rest of LAMEA Joint Pain Injections Market by Injection Type
6.7.2 Rest of LAMEA Joint Pain Injections Market by Distribution Channel
6.7.3 Rest of LAMEA Joint Pain Injections Market by Joint Type
Chapter 7. Company Profiles
7.1 Bioventus Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.2 Pacira BioSciences, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Research & Development Expenses
7.2.4 Recent strategies and developments:
7.2.4.1 Acquisition and Mergers:
7.3 AbbVie, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Trails and Approvals:
7.4 Teva Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional & Segmental Analysis
7.5.4 Research & Development Expense
7.6 Anika Therapeutics, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Zimmer Biomet Holdings, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Eli Lilly And Company
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expenses
7.9 Ferring Holdings SA
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research and Development Expense
7.10. Sanofi S.A.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
Companies Mentioned
- Bioventus Inc.
- Pacira BioSciences, Inc.
- AbbVie, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Pfizer, Inc.
- Anika Therapeutics, Inc.
- Zimmer Biomet Holdings, Inc.
- Eli Lilly And Company
- Ferring Holdings SA
- Sanofi S.A.
Methodology
LOADING...
